Data Collection in Clinical Toxicology: Are There Too Many Variables?*
暂无分享,去创建一个
[1] L Aarons. Pharmacokinetic and pharmacodynamic modelling in drug development. , 1999, Statistical methods in medical research.
[2] B. Charles. Fundamentals of Population Modelling Opportunities for Hospital Pharmacy Practice , 1999 .
[3] L. Aarons. Statistical methods in laboratory medicine , 1999 .
[4] L Aarons,et al. Software for Population Pharmacokinetics and Pharmacodynamics , 1999, Clinical pharmacokinetics.
[5] D. Reith,et al. Relative toxicity of beta blockers in overdose. , 1996, Journal of toxicology. Clinical toxicology.
[6] F. Charatan. Exercise and diet reduce risk of diabetes, US study shows , 2001, BMJ : British Medical Journal.
[7] I. Whyte,et al. Preformatted admission charts for poisoning admissions facilitate clinical assessment and research. , 1999, Annals of emergency medicine.
[8] J. Sayers. The world health report 2001 - Mental health: new understanding, new hope , 2001 .
[9] D. Reith,et al. Acetaminophen Causes an Increased International Normalized Ratio by Reducing Functional Factor VII , 2000, Therapeutic drug monitoring.
[10] I. Whyte,et al. Relative toxicity of benzodiazepines in overdose , 1995, BMJ.
[11] I. Whyte,et al. Correlations between prescriptions and drugs taken in self‐poisoning: Implications for prescribers and drug regulation , 1995, The Medical journal of Australia.
[12] E. Vicaut,et al. Brief report: treatment of severe colchicine overdose with colchicine-specific Fab fragments. , 1995, The New England journal of medicine.
[13] C. Stiller,et al. Centralised treatment, entry to trials and survival. , 1994, British Journal of Cancer.
[14] K. Ball,et al. Repetition of deliberate self‐poisoning in an Australian hospital‐treated population , 1999, The Medical journal of Australia.
[15] N. Buckley,et al. Can the Fatal Toxicity of Antidepressant Drugs be Predicted with Pharmacological and Toxicological Data? , 1998, Drug safety.
[16] I. Whyte,et al. Clinical features and management of Hadronyche envenomation in man. , 2000, Toxicon : official journal of the International Society on Toxinology.
[17] I. Whyte,et al. Self‐poisoning in Newcastle, 1987‐1992 , 1995, The Medical journal of Australia.
[18] I. Whyte,et al. An analysis of age and gender influences on the relative risk for suicide and psychotropic drug self‐poisoning , 1996, Acta psychiatrica Scandinavica.
[19] D. Gunnell,et al. Paracetamol recall: a natural experiment influencing analgesic poisoning , 2002 .
[20] C. Dolea,et al. World Health Organization , 1949, International Organization.
[21] I. Whyte,et al. Progress in clinical toxicology: from case reports to toxicoepidemiology , 1995, The Medical journal of Australia.
[22] S. Sutherland. Antivenom to the venom of the male Sydney funnel-web spider Atrax robustus: preliminary report. , 1980, The Medical journal of Australia.
[23] N. Buckley,et al. Greater toxicity in overdose of dothiepin than of other tricyclic antidepressants , 1994, The Lancet.
[24] Anthony J. Smith,et al. Evidence-based medicine in toxicology: where is the evidence? , 1996, The Lancet.
[25] M. Tenenbein. Good reasons to publish in Clinical Toxicology. , 1998, Journal of toxicology. Clinical toxicology.
[26] P. Appelqvist,et al. Lye corrosion carcinoma of the esophagus. A review of 63 cases , 1980, Cancer.
[27] K. Burgess,et al. Funnel-web spider (Atrax robustus) antivenom. 2. Early clinical experience. , 1981, Medical Journal of Australia.
[28] I M Whyte,et al. Interrater agreement in the measurement of QRS interval in tricyclic antidepressant overdose: implications for monitoring and research. , 1996, Annals of emergency medicine.
[29] I. Whyte,et al. Cardiotoxicity more common in thioridazine overdose than with other neuroleptics. , 1995, Journal of toxicology. Clinical toxicology.
[30] I. Whyte,et al. Pheniramine — a much abused drug , 1994, The Medical journal of Australia.
[31] N. Black. Why we need observational studies to evaluate the effectiveness of health care , 1996, BMJ.
[32] J. McGrath,et al. A survey of deliberate self‐poisoning , 1989, The Medical journal of Australia.
[33] I. Whyte,et al. The effect of the introduction of safety packaging for carbamazepine on toxicity in overdose in adults , 1995 .
[34] N. Buckley,et al. POISONING AND EPIDEMIOLOGY: ‘TOXICOEPIDEMIOLOGY’ , 1998, Clinical and experimental pharmacology & physiology.
[35] I. Whyte,et al. Oral or intravenous N-acetylcysteine: which is the treatment of choice for acetaminophen (paracetamol) poisoning? , 1999, Journal of toxicology. Clinical toxicology.
[36] I. Whyte,et al. Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants. , 2003, QJM : monthly journal of the Association of Physicians.
[37] F. Charatan. Bayer decides to withdraw cholesterol lowering drug , 2001, BMJ : British Medical Journal.
[38] G. Carter,et al. A model for the management of self‐poisoning , 1997, The Medical journal of Australia.
[39] Alan D. Lopez,et al. The global burden of disease: a comprehensive assessment of mortality and disability from diseases injuries and risk factors in 1990 and projected to 2020. , 1996 .
[40] I. Deary,et al. Consent for transfusion , 1997, BMJ.
[41] I. Whyte,et al. Activated charcoal reduces the need for N-acetylcysteine treatment after acetaminophen (paracetamol) overdose. , 1999, Journal of toxicology. Clinical toxicology.
[42] B. Charlton,et al. The PACE (population-adjusted clinical epidemiology) strategy: a new approach to multi-centred clinical research. , 1997, QJM : monthly journal of the Association of Physicians.
[43] L. Aarons,et al. Methodological approaches to the population analysis of toxicity data. , 2001, Toxicology letters.